###begin article-title 0
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 72 76 <span type="species:ncbi:10090">Mice</span>
Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: CC TL LY JC. Performed the experiments: CC TL CL JC. Analyzed the data: CC TL CL JC. Contributed reagents/materials/analysis tools: CC LY. Wrote the paper: CC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 453 458 <span type="species:ncbi:10090">mouse</span>
Pten functionally acts as a tumor suppressor gene. Lately, tissue-specific ablation of Pten gene in mice has elucidated the role of Pten in different tumor progression models. However, a temporally controlled Pten loss in all adult tissues to examine susceptibility of various tissues to Pten-deficient tumorigenesis has not been addressed yet. Our goal was to explore the genesis of Pten-deficient malignancies in multiple tissue lineages of the adult mouse.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 51 62 51 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten exon 5</italic>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 113 118 113 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 89 118 89 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26 (R26)-CreER<sup>T</sup>;Pten<sup>fx/fx</sup></italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 203 208 203 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 188 208 188 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>;Pten<sup>fx/fx</sup></italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 926 930 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1047 1051 1035 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1099 1100 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
We utilized an inducible Cre/loxP system to delete Pten exon 5 in the systemic organs of ROSA26 (R26)-CreERT;Ptenfx/fx mice. On reaching 45 weeks 4OHT-induced Pten loss, we found that the R26-CreERT;Ptenfx/fx mice developed a variety of malignancies. Overall tumor mean latency was 17 weeks in the Pten-deficient mice. Interestingly, mutant females developed malignancies more quickly at 10approximately11 weeks compared with a tumor latency of 21 weeks for mutant males. Lymphoma incidence (76.9% in females; 40.0% in males) was higher than the other malignancies found in the mutant mice. Mutant males developed prostate (20.0%), intestinal cancer (35.0%) and squamous cell carcinoma (10.0%), whereas the mutant females developed squamous cell carcinoma (15.4%) and endometrial cancer (46.1%) in addition to lymphomas. Furthermore, we tested the pharmacological inhibition of the PTEN downstream effectors using LY294002 on Pten-deficient prostate hyperplasia. Our data revealed that, indeed, the prostate hyperplasia resulting from the induced Pten loss was significantly suppressed by LY294002 (p = 0.007).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 289 294 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 273 294 273 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>; Pten<sup>fx/fx</sup></italic>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
Through monitoring a variety of Pten-deficient tumor formation, our results revealed that the lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the Pten gene is excised. Therefore, this R26-CreERT; Ptenfx/fx mouse model may provide an entry point for understanding the role of Pten in the tumorigenesis of different organs and extend the search for potential therapeutic approaches to prevent Pten-deficient malignancies.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 601 604 601 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Stambolic1">[1]</xref>
###xml 606 609 606 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Wu1">[2]</xref>
###xml 762 765 762 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Maehama1">[3]</xref>
###xml 1051 1054 1051 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Stambolic1">[1]</xref>
###xml 1056 1059 1056 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Cully1">[4]</xref>
Tumors occur in normal tissues that are challenged by a variety of genetic and environmental risk factors. These risk factors may consequently evoke aberrant effects on cytoplasmic signaling network, which result in uncontrolled cellular proliferation, cell survival and heterotypic cross-talk with neighboring cells. Among the various types of complicated cellular signaling circuitry that have been identified, the tumor suppressor PTEN, a phosphatase and tension homolog on chromosome 10, acts as the most important negative regulator of the phosphatidylinositol 3-kinase (PI-3K) signaling pathway [1], [2]. PTEN converts PIP3 to phosphatidylinositol (4,5) diphosphate (PIP2) in order to maintain a homeostasis of PIP3, which is generated by PI-3K activation [3]. Inactivation of PTEN results in an accumulation of PIP3, which recruits the serine/threonine kinase PKB/AKT to the cell membrane and this further activate downstream of the PI-3K/AKT signaling pathway to promote cellular proliferation, anti-apoptosis, cell survival and tumorigenesis [1], [4].
###end p 9
###begin p 10
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 48 51 48 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Steck1">[5]</xref>
###xml 53 56 53 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Li1">[6]</xref>
###xml 58 61 58 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Teng1">[7]</xref>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-DiCristofano1">[8]</xref>
###xml 206 209 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Stambolic2">[9]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Sun1">[10]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Suzuki1">[11]</xref>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 586 589 586 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-DiCristofano1">[8]</xref>
###xml 591 594 591 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Stambolic2">[9]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Suzuki1">[11]</xref>
###xml 602 606 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Podsypanina1">[12]</xref>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 688 691 688 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 684 691 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>+/&#8722;</sup></italic>
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Stambolic2">[9]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Suzuki1">[11]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Podsypanina1">[12]</xref>
###xml 756 762 756 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx3.1</italic>
###xml 764 769 764 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trp53</italic>
###xml 773 780 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27KIP1</italic>
###xml 892 895 892 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>+/&#8722;</sup></italic>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Kim1">[13]</xref>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Chen1">[14]</xref>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Freeman1">[15]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-AbateShen1">[16]</xref>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-DiCristofano2">[17]</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
Mutation of PTEN is often seen in human cancers [5], [6], [7]. Using a gene targeting strategy to ablate Pten gene function in the mouse causes embryonic lethality between days 6.5 to 9.5 of gestation [8], [9], [10], [11]. The early lethality of Pten-deficient mice limits our understanding regarding how PTEN regulates downstream signaling and is related to tumorigenesis at adult stage. Up to this point, mice heterozygous for Pten have provided some basis for study because they develop a variety of cancers, including breast cancer, endometrial cancer, prostate tumors and lymphoma [8], [9], [11], [12]. Loss-of-heterozygosity of Pten might contribute to the tumor development in Pten+/- mice[9], [11], [12]. In addition, other genetic lesions such as Nkx3.1, Trp53 or p27KIP1 might be involved in decreasing latency and increasing invasiveness/metastasis during tumor development in Pten+/- mice [13], [14], [15], [16], [17].
###end p 10
###begin p 11
###xml 36 40 36 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Kwan1">[18]</xref>
###xml 42 46 42 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Metzger1">[19]</xref>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 208 213 208 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 204 213 204 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Wang1">[20]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Ma1">[21]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Backman1">[22]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Trotman1">[23]</xref>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Yilmaz1">[24]</xref>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Yilmaz1">[24]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Wang2">[25]</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-He1">[26]</xref>
###xml 837 841 837 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 926 930 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1003 1007 1003 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1108 1112 1108 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 239 254 <span type="species:ncbi:10090">transgenic mice</span>
###xml 322 347 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 349 353 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 447 453 <span type="species:ncbi:9606">humans</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
Using Cre-loxP conditional genetics [18], [19], tissue-specific inactivation of Pten results in tumor formation in the targeted tissues of the mouse. Prostate-specific ablation of loxP-flanked Pten gene (Ptenfx/fx) utilizing different Cre transgenic mice lines such as probasin-Cre, prostate-specific antigen (PSA)-Cre or mouse mammary tumor virus (MMTV)-Cre has shown the occurrence of prostate cancer progression similar to that which occurs in humans [20], [21], [22], [23]. Likewise, conditionally ablating the Pten gene in hematopoietic lineages causes various leukemias in the mouse [24]. Such Cre activity might also be present in the disease-initiating stem cells from which the Pten gene is deleted, which is followed by tumor initiation, expansion and progression [24], [25], [26]. Thus, tissue-specific and cell type-specific Pten knockout mice have provided a fundamental basis for an understanding of the role of Pten in different tumor progression models. However, somatic inactivation of Pten in a temporally controlled manner in all adult tissues to test susceptibility of various tissues to Pten-deficient tumorigenesis has not been carried out up to the present.
###end p 11
###begin p 12
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 125 166 125 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26 Cre-estrogen receptor (R26-CreER<sup>T</sup>)</italic>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26</italic>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Badea1">[27]</xref>
###xml 297 302 297 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 293 302 293 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Lesche1">[28]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Groszer1">[29]</xref>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 551 556 551 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 534 556 534 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>/+;Pten<sup>fx/fx</sup></italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 852 856 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 992 996 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
To assess the tumor incidence, latency and spectrum of Pten-deficient adult mice, we utilize two mouse strains: firstly, the ROSA26 Cre-estrogen receptor (R26-CreERT) knock-in mouse line, which expresses inducible Cre recombinase driven by the ubiquitous promoter ROSA26[27] and secondly, the Ptenfx/fx mouse carrying loxP-flanked exon 5 encoding the phosphatase domain of PTEN [28], [29]. 4-hydroxytamoxifen (4-OHT) is administrated to induce the Pten gene excision in a temporally controlled manner in the crossed mutant offspring (R26-CreERT/+;Ptenfx/fx). In this report, we found that lymphoid lineages, the squamous epithelium of the epidermis, the simple epithelium of the prostate, the endometrium and the intestine are highly susceptible to tumorigenesis in such a Pten-deficient background. Application of the PI3K inhibitor LY294002 in these Pten-deficient mice resulted in the enlargement of the anterior prostate glands being significantly suppressed. Thus, we have established a Pten-deficient tumor model, which demonstrates that multiple cell lineages can be provoked to undergo aberrant cellular signaling simultaneously and that this results in major changes of normal tissues.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Temporally controlled CreER-mediated recombination by 4OHT administration
###end title 14
###begin p 15
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 34 44 34 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup></italic>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Badea1">[27]</xref>
###xml 223 224 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 214 230 214 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>; R26R</italic>
###xml 486 487 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 477 492 474 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>;R26R</italic>
###xml 519 527 516 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 519 527 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g001"><bold>Figure 1</bold></xref>
###xml 641 649 638 646 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 641 649 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g001"><bold>Figure 1</bold></xref>
###xml 739 740 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 730 740 727 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup></italic>
###xml 45 60 <span type="species:ncbi:10090">transgenic mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 741 756 <span type="species:ncbi:10090">transgenic mice</span>
The inducible Cre activity of the R26-CreERT transgenic mice was demonstrated in neuronal tissues by Badea et al. [27]. In this report, we have examined temporally controlled Cre activity in the systemic organs of R26-CreERT; R26R bigenic mice. After 4OHT treatment for one week, whole mount X-gal staining revealed that the 4OHT-induced beta-galactosidase expression showed focal or mosaic blue patterns in the brain, liver, pancreas, kidney, intestine, uterus and bladder of R26-CreERT;R26R bigenic males or females (Figure 1). Non-specific X-gal staining was also observed in the hind-stomach, the gut, the prostate and the vas deferens (Figure 1 and data not shown). These results suggested that the inducible Cre activity of R26-CreERT transgenic mice had been successfully controlled by 4OHT in a variety of organs, although the level of inducible Cre activity may have differed as indicated by the variable X-gal stained intensity among these systemic organs.
###end p 15
###begin title 16
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 48 63 48 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26CreER<sup>T</sup>; R26R</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Evaluation of 4OHT-induced Cre recombination in R26CreERT; R26R mice.
###end title 16
###begin p 17
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 192 206 192 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26CreER<sup>T</sup>;R26R</italic>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 632 646 632 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26CreER<sup>T</sup>;R26R</italic>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 675 689 675 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26CreER<sup>T</sup>;R26R</italic>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 464 469 <span type="species:ncbi:10090">mouse</span>
After 10 days of 4OHT or vehicle control (DMSO) injection, LacZ reporter activity in the systemic organs including brain, liver, spleen, pancreas, kidney, intestine and reproductive tracts of R26CreERT;R26R mice (2 males and 2 females) were examined by X-gal staining and compared with those of the control mice. The representative X-gal staining patterns in the systemic organs of a DMSO-treated control male mouse and the reproductive organs of a control female mouse are shown in the left panels. Representative X-gal positive (blue) patterns reflecting inducible Cre activity are shown in the other panels (middle, 4OHT-treated R26CreERT;R26R female; right, 4OHT-treated R26CreERT;R26R male). A, adrenal gland; AP, anterior prostate; B, bladder; O, ovary; Ov, oviduct; SV, seminal vesicle; U, uterus; VD, vas deferens
###end p 17
###begin p 18
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 111 116 111 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 95 116 95 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER/+;Pten<sup>fx/fx</sup></italic>
###xml 141 146 141 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 133 146 133 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 179 183 179 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 171 183 171 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 185 193 185 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/+</sup></italic>
###xml 201 206 201 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 197 206 197 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 303 312 303 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 303 312 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g002"><bold>Figure 2A</bold></xref>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 511 515 511 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 507 515 507 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/+</sup></italic>
###xml 525 529 525 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 517 529 517 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 542 547 542 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 534 547 534 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 559 568 559 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g002"><bold>Figure 2B</bold></xref>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 651 655 651 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 643 655 643 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 668 673 668 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 660 673 660 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 748 751 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 793 802 793 802 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 793 802 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g002"><bold>Figure 2B</bold></xref>
###xml 841 845 841 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 921 925 921 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 913 925 913 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 937 942 937 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 929 942 929 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1037 1041 1037 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 1029 1041 1029 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 1053 1058 1053 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1045 1058 1045 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1065 1074 1065 1074 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 1065 1074 1065 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g002"><bold>Figure 2B</bold></xref>
###xml 1231 1236 1231 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1223 1236 1223 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1258 1262 1258 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 1250 1262 1250 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 1685 1690 1685 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1677 1690 1677 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1697 1706 1697 1706 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 1697 1706 1697 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g002"><bold>Figure 2C</bold></xref>
###xml 1826 1831 1826 1831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1818 1831 1818 1831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1879 1888 1879 1888 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1</bold>
###xml 1879 1888 1879 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001237.s001"><bold>Figure S1</bold></xref>
###xml 1988 1993 1988 1993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1980 1993 1980 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 2000 2013 2000 2013 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B &amp; C</bold>
###xml 2000 2013 2000 2013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g002"><bold>Figure 2B &amp; C</bold></xref>
###xml 2015 2024 2015 2024 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1</bold>
###xml 2015 2024 2015 2024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001237.s001"><bold>Figure S1</bold></xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1691 1695 <span type="species:ncbi:10090">mice</span>
###xml 1848 1852 <span type="species:ncbi:10090">mice</span>
###xml 1994 1998 <span type="species:ncbi:10090">mice</span>
To investigate tumor susceptibility in the Pten-deficient mice at an adult stage, we generated R26-CreER/+;Ptenfx/fx (referred to as R26-Ptenfx/fx hereafter) and control (R26-Ptenfx/+, Ptenfx/+ or Ptenfx/fx) mice and followed this with 4OHT induced Cre/loxP recombination to excise exon 5 of Pten gene (Figure 2A). After 4OHT treatment for one week, we examined the efficiency of exon 5 of Pten gene excision using the genomic PCR method in a variety of organs dissected from males and females carrying the Ptenfx/+, R26-Ptenfx/+ and R26-Ptenfx/fx genotypes (Figure 2B). Our result showed that exon 5 of the Pten gene excision was detected in R26-Ptenfx/+ and R26-Ptenfx/fx tissues, indicating that 4OHT was able to induce Cre-mediated excision of loxP-flanked region in the tissues examined (Figure 2B). Notably, the excision efficiency of Pten showed no overt differences between males and females carrying the R26-Ptenfx/+ or R26-Ptenfx/fx genotypes. However, inducible Cre activity may vary slightly across the organs of the R26-Ptenfx/+ or R26-Ptenfx/fx mice (Figure 2B). We next examined the expression of PTEN protein in selected organs, specifically the anterior prostate and the intestinal tract, of 4OHT-injected R26-Ptenfx/fx and control (R26-Ptenfx/+) mice using immunofluorescence microscopy. Our results showed that PTEN could be detected in the prostate and colon epithelium, which was indicated by cytokeratin 8 (CK8) staining of the controls (yellow; CK8-positive, PTEN-positive). In contrast, PTEN expression was lost in most of the hyperplastic epithelial lesions and tumor lesions (red; CK8-positive, PTEN-negative) found in the corresponding organs of the R26-Ptenfx/fx mice (Figure 2C). We also examined the expression of PTEN in various other systemic organs, namely the lung and the kidney, of R26-Ptenfx/fx and the control mice to demonstrate PTEN loss (Figure S1). Our results suggested that the majority of PTEN was lost from the systemic organs of the R26-Ptenfx/fx mice (Figure 2B & C; Figure S1).
###end p 18
###begin title 19
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 52 57 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 35 57 35 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>/+;Pten<sup>fx/fx</sup></italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Temporally controlled Pten loss in R26-CreERT/+;Ptenfx/fx mice.
###end title 19
###begin p 20
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 58 71 58 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26-CreER<sup>T</sup></italic>
###xml 99 110 99 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten exon 5</italic>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CreER<sup>T</sup></italic>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 364 376 364 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten exon 5.</italic>
###xml 724 728 724 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 720 728 720 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/+</sup></italic>
###xml 741 745 741 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 733 745 733 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 763 767 763 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 755 767 755 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 787 792 787 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 779 792 779 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 810 815 810 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 802 815 802 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1341 1345 1301 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 1333 1345 1293 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 1358 1363 1318 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1350 1363 1310 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1648 1652 1608 1612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 1640 1652 1600 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 1753 1758 1713 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1745 1758 1705 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1930 1935 1890 1895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1922 1935 1882 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1364 1368 <span type="species:ncbi:10090">mice</span>
###xml 1653 1657 <span type="species:ncbi:10090">mice</span>
###xml 1759 1763 <span type="species:ncbi:10090">mice</span>
(A) Illustration of Pten conditional (floxed; fx) allele, ROSA26-CreERT transgene and 4OHT-induced Pten exon 5 excision. The CreERT fusion protein (inactive) was initially expressed under a ubiquitous promoter ROSA26. The 4OHT inducer was used to temporally active the CreERT recombinase activity, which resulted in the excision of the DNA fragment containing the Pten exon 5. (B). PCR genotyping of the Pten floxed allele and Cre-mediated exon 5 excision; After one week of 4OHT injection, genomic DNA was isolated individually from multiple organs including the lung, the liver, the intestine, the kidney, the spleen, the thymus, the tail, the anterior prostate and the uterus of mice carrying different genotypes (C, Ptenfx/+; 1, R26-Ptenfx/+ male; 2, R26-Ptenfx/+ female; 3, R26-Ptenfx/fx male; 4, R26-Ptenfx/fx female). PCR genotyping is shown that allows the identification of the Pten floxed allele (approximately1100-bp), the wild-type (approximately1000-bp) and the exon 5 excised alleles (Delta5; approximately400-bp) from the 4OHT-treated mice. (C). Immunostaining of PTEN in the prostate and the colon. Representative merged images of the immunofluorescence analysis reveal the expression level of PTEN in the anterior prostate lobe (at 7 weeks post-4OHT treatment) and the colon (at 37 weeks post-4OHT treatment) of the R26-Ptenfx/+ and R26-Ptenfx/fx mice. Antibody against PTEN (green) and TROMA-I antibody against cytokeratin 8 (CK8; red) were used to study the expression of PTEN in the simple epithelial subsets. Arrows indicated the coexpression of PTEN and CK8 (yellow) in anterior prostate gland and colon epithelium of R26-Ptenfx/+ mice (left panels), whereas the hyperplastic epithelial subsets (middle panels; red) of the R26-Ptenfx/fx mice showing PTEN loss (arrowheads). In addition, the immunofluorescence images in the right panels reveal PTEN loss in the tumor lesions of prostate and colon of R26-Ptenfx/fx males (at 13 and 39 weeks, respectively). Scale Bar, 200 microm.
###end p 20
###begin title 21
###xml 20 25 20 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 12 25 12 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 30 42 30 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
Analysis of R26-Ptenfx/fx and R26-Ptenfx/+ malignancies
###end title 21
###begin p 22
###xml 21 26 21 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 13 26 13 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 78 83 78 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 74 83 74 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 101 105 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 93 105 93 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 416 421 416 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 408 421 408 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 452 461 452 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figure 3A</bold></xref>
###xml 503 508 503 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 495 508 495 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 576 583 576 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 576 583 576 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001237-t001"><bold>Table 1</bold></xref>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 691 695 691 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 683 695 683 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 786 793 786 793 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 786 793 786 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001237-t001"><bold>Table 1</bold></xref>
###xml 822 826 822 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 814 826 814 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 895 899 895 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 887 899 887 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 972 976 972 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 964 976 964 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 1036 1043 1036 1043 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1036 1043 1036 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001237-t001"><bold>Table 1</bold></xref>
###xml 1045 1054 1045 1054 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 1045 1054 1045 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001237.s002"><bold>Figure S2</bold></xref>
###xml 1103 1108 1103 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1099 1108 1099 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 827 832 <span type="species:ncbi:10090">mouse</span>
###xml 982 987 <span type="species:ncbi:10090">mouse</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
Furthermore, R26-Ptenfx/fx (n = 33; 20 males and 13 females) and control (Ptenfx/fx, n = 24; R26-Ptenfx/+, n = 21) mice were given 4-OHT injection (i.p.) at age of 6 weeks and then monitored for tumor development over about 60 weeks. The mice were sacrificed for pathological analysis (H&E and IHC) when they manifested sign of distress or on tumor detection. The cumulated tumor-free survival curves of the R26-Ptenfx/fx and control mice are shown in Figure 3A. Our results showed that all the R26-Ptenfx/fx mice died from their tumor burden by 45 weeks post 4OHT injection (Table 1). The overall mean latency of Pten-deficient tumor formation was 17 weeks. In addition, we found 4 R26-Ptenfx/+ mice (19.0%) developed various different types of tumors by 60 weeks post 4OHT treatment (Table 1). We found that one R26-Ptenfx/+ mouse suffered from metastatic lung cancer at 42 weeks, two R26-Ptenfx/+ females developed mammary tumors at 52 and 55 weeks and another R26-Ptenfx/+ male mouse developed hepatocellular carcinoma at 58 weeks (Table 1; Figure S2). No tumors were found in the control group Ptenfx/fx mice at 60 weeks.
###end p 22
###begin title 23
###xml 67 72 67 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 59 72 59 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Tumor-free survival, tumor spectrum and tumor incidence of R26-Ptenfx/fx mice.
###end title 23
###begin p 24
###xml 31 36 31 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 46 50 46 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 38 50 38 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 63 68 63 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 55 68 55 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 126 131 126 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 118 131 118 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 198 203 198 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 190 203 190 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 427 432 427 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 419 432 419 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 504 509 504 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 496 509 496 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
(A) Tumor-free survival of Ptenfx/fx, R26-Ptenfx/+ and R26-Ptenfx/fx mice; (B) Tumor-free survival of male and female R26-Ptenfx/fx mice; (C) Tumor spectrum and incidence of male and female R26-Ptenfx/fx mice; Lym, lymphomas; PC, prostate cancer; EC, endometrial cancer; IC, intestinal cancer; SCC, squamous cell carcinoma; The percentage of each tumor type is shown on the right of bar graph. (D) Tumor latency of the R26-Ptenfx/fx mice; each dot represents an individual malignant tumor in the R26-Ptenfx/fx mice. , Lymphoma (Lym); blacksquare, square, filled, Squamous cell carcinoma (SCC); black triangle, Intestinal cancer (IC); *, prostate cancer (PC); Bars represent the mean tumor latency.
###end p 24
###begin title 25
###xml 24 28 24 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 16 28 16 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 41 46 41 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 33 46 33 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Malignancies of R26-Ptenfx/+ and R26-Ptenfx/fx mice
###end title 25
###begin p 26
###xml 38 43 38 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 30 43 30 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Multiple tumors were found in R26-Ptenfx/fx mice (5 females and 4 males).
###end p 26
###begin p 27
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 144 149 144 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 136 149 136 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 244 253 244 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 244 253 244 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figure 3B</bold></xref>
###xml 269 274 269 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 261 274 261 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 473 482 473 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 473 482 473 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figure 3C</bold></xref>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 832 837 832 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 824 837 824 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 872 877 872 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 864 877 864 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1078 1087 1078 1087 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 1078 1087 1078 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figure 3C</bold></xref>
###xml 1142 1151 1142 1151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figure 3D</bold></xref>
###xml 1186 1190 1186 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1392 1401 1392 1401 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 1392 1401 1392 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figure 3D</bold></xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
Interestingly, we found that the tumor latency and spectrum of the Pten-deficient mice exhibited gender differences. Approximately, 50% R26-Ptenfx/fx males and females had malignant tumors at 21 weeks and between 10 and 11 weeks, respectively (Figure 3B). Most R26-Ptenfx/fx females quickly developed lymphomas (10 of 13; 76.9%) and died at about 9 weeks post-4OHT injection compared to a much lower incidence of lymphoma formation (8 of 20; 40%) by 13 weeks in the males (Figure 3C). The Pten-deficient male mice developed intestinal cancers (7 of 20, 35%) arising from the colorectum (n = 6) and small intestine (n = 1), whereas no female mice developed this type of cancer. This might be partly due to the quick development of the lymphomas, which caused early lethality before the intestinal cancer could develop in the R26-Ptenfx/fx females. In addition, the R26-Ptenfx/fx mice developed squamous cell carcinoma of the epidermis (4 of 33 mice, 12.1%; 2 males, 10% and 2 females, 15.4%), endometrial cancer (6 of 13 females, 46.1%) and prostate cancer (4 of 20 males, 20%) (Figure 3C). The mean latency of these malignancies is showed in Figure 3D. The sequential occurrence of the Pten-deficient malignancies was about 11 weeks for the lymphomas and the endometrial cancer, about 19 weeks for the prostate cancer and squamous cell carcinoma and about 30 weeks for the intestinal cancer (Figure 3D).
###end p 27
###begin p 28
###xml 124 133 124 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 124 133 124 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g004"><bold>Figure 4A</bold></xref>
###xml 277 286 277 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 277 286 277 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g004"><bold>Figure 4A</bold></xref>
###xml 590 599 590 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 590 599 590 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g004"><bold>Figure 4B</bold></xref>
###xml 1109 1114 1109 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1101 1114 1101 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1150 1159 1150 1159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 1150 1159 1150 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g004"><bold>Figure 4C</bold></xref>
###xml 1328 1332 1328 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 1115 1120 <span type="species:ncbi:10090">mouse</span>
###xml 1185 1190 <span type="species:ncbi:10090">mouse</span>
The lymphomas mainly arose from the thymus and mesenteric lymph nodes. A representative thymic lymphoma is shown grossly in Figure 4A. H&E staining revealed a mature appearance for the small lymphocytic cells and a loss of cortical-medullary architecture in this thymic tumor (Figure 4A). To verify the potential origins of this lymphoma, T-cell and B-cell origins were respectively determined by antibodies against CD3 and B220 in the liver with the infiltrated lymphoid tumor cells in the portal area identified using IHC, which showed that this tumor was a CD3-positive T-cell lymphoma (Figure 4B). Through evaluation of CD3 and B220 expression in the lymphomas formed in the mutant mice, we found that all lymphomas were derived from CD3-positive T-cells with either a mature appearance of small lymphocytes or large lymphoblasts (data not shown). Occasionally, the more detail surface markers that were expressed on these lymphomas were analyzed by flow cytometry in order to assist our verification of these lymphomas. As an example, a CD4-rich T-cell lymphomas was found to have developed in a R26-Ptenfx/fx mouse at six weeks post-treatment (Figure 4C). We also found that one mouse developed both CD4- and CD8-rich lymphomas arising from the thymus and mesenteric lymph node, respectively, suggesting that 4OHT-induced Pten loss in different lymphoid origins may develop simultaneously (data not shown).
###end p 28
###begin title 29
###xml 28 33 28 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 20 33 20 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
Characterization of R26-Ptenfx/fx lymphomas.
###end title 29
###begin p 30
###xml 34 39 34 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 26 39 26 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 134 140 134 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> fx/fx</sup>
###xml 126 140 126 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup> fx/fx</sup></italic>
###xml 365 370 361 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 357 370 353 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 750 755 742 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 742 755 734 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 371 376 <span type="species:ncbi:10090">mouse</span>
###xml 756 761 <span type="species:ncbi:10090">mouse</span>
(A) Gross morphology of a R26-Ptenfx/fx thymic tumor enlarged compared to the control (ctrl) thymus. H&E stained section of a R26-Pten fx/fx thymic tumor reveals the morphology of the small lymphocytic cells in comparison to the control (ctrl). C, cortex; M, medulla; Scale Bar, 200 microm (B) Infiltrated lymphocytic tumor cells (arrows) in the liver of a R26-Ptenfx/fx mouse characterized by H&E (left) and IHC antibodies against CD3 (middle; positive stained brown cells) and B220 (right; negative stained blue cells), which allow the assessment of the origin of the tumor. Scale bar, 200m; High-power views of CD3 or B220 IHC are inserted (scale bar, 100 microm). (C) Flow cytometry analysis of thymocyte suspensions from a control and a R26-Ptenfx/fx mouse stained with antibodies against CD4 and CD8. Percentage of cells is indicated in each quadrant.
###end p 30
###begin p 31
###xml 148 153 148 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 140 153 140 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 187 196 187 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3</bold>
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g003"><bold>Figures 3</bold></xref>
###xml 196 199 196 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &amp; </bold>
###xml 199 200 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</bold>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g005"><bold>5</bold></xref>
###xml 361 369 361 369 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 361 369 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g005"><bold>Figure 5</bold></xref>
###xml 491 496 491 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 483 496 483 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 503 511 503 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g006"><bold>Figure 6</bold></xref>
###xml 536 541 536 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 528 541 528 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 621 634 621 634 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6A &amp; B</bold>
###xml 621 634 621 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g006"><bold>Figure 6A &amp; B</bold></xref>
###xml 761 770 761 770 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6C</bold>
###xml 761 770 761 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g006"><bold>Figure 6C</bold></xref>
###xml 943 952 931 940 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6D</bold>
###xml 943 952 931 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g006"><bold>Figure 6D</bold></xref>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
In addition to lymphomas, prostate cancer, endometrial cancer, intestinal cancer and squamous cell carcinoma of the epidermis were found in R26-Ptenfx/fx mice using H&E and IHC analyses (Figures 3 & 5). The focal invasions of the prostate, endometrial and colorectal carcinomas were observed and characterized by H&E or IHC using antibodies against E-cadherin (Figure 5). Pre-cancer lesions (hyperplasia/dysplasia and adenoma) of corresponding malignancies were also observed in the R26-Ptenfx/fx mice (Figure 6). We found that R26-Ptenfx/fx males had developed small or large intestinal polyps at late onset (>35 weeks; Figure 6A & B). In addition, most mutant females developed endometrial hyperplasia (7 of 13) at between 7 and 9 weeks post-4-OHT injection (Figure 6C). The early alternations associated with prostate hyperplasia (BPH) or prostate intraepithelial neoplasm (PIN) were observed at 4approximately6 weeks post 4-OHT injection (Figure 6D).
###end p 31
###begin title 32
###xml 9 14 9 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> R26-Pten<sup>fx/fx</sup></italic>
 R26-Ptenfx/fx epithelial malignancies.
###end title 32
###begin p 33
###xml 127 132 127 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 119 132 119 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
Representative histology (middle panels; H&E) and E-cadherin IHC (right panels; E-cad; NovaRed) of malignant tumors of R26-Ptenfx/fx prostate, uterus, colorectum and skin tissue are showed to compare with the normal corresponding organs (left panels; H&E) from control mice. Red arrowheads indicated the invasive border of the prostatic, endometrial and colorectal cancers. High-magnification views of E-cadherin IHC revealing intense membranous staining are shown in the inserted photos (Bars, 100 microm). Bidirectional arrows indicated the endometrial portions. M, myometrium; E, endometrium; Scale bars, 200 microm.
###end p 33
###begin title 34
###xml 30 35 30 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 22 35 22 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Pre-cancer lesions of R26-Ptenfx/fx mice.
###end title 34
###begin p 35
###xml 120 125 120 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 112 125 112 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 295 300 295 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 287 300 287 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 462 467 462 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 454 467 454 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 648 653 648 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 640 653 640 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
(A & B) Representative H&E stained sections revealed the polyps of the small intestine (A) and the colon (B) of R26-Ptenfx/fx males at 31 and 39 weeks 4OHT post-treatment, respectively. (C) Representative H&E stain revealing complex atypical hyperplasia of the endometrim was found in a R26-Ptenfx/fx female, which also suffered from lymphoma, at 11 weeks 4OHT post-treatment. M, myometrium; (D) Representative histology of high grade PIN was found in a R26-Ptenfx/fx male at 7 weeks post 4OHT injection. Arrowheads indicated the dysplastic epithelial lesions of the intestine (A & B), the uterus (C) and the anterior prostate gland (D) of R26-Ptenfx/fx mice. Scale bars, 200 microm.
###end p 35
###begin p 36
###xml 56 61 56 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 48 61 48 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Moreover, multiple tumors were also observed in R26-Ptenfx/fx mice (9 of 33, 27.3%; 5 females and 4 males). Among these animals, all females developed T-cell lymphoma and endometrial cancer at 7approximately23 weeks post-4OHT injection. One of these females also developed squamous cell carcinoma additionally. Furthermore, two males developed prostate cancer together with lymphoma (at 13 weeks) and colorectal cancer (at 27 weeks), respectively. Finally, two males developed squamous cell carcinomas and colorectal cancer at 28 and 31 weeks post-4OHT injection.
###end p 36
###begin title 37
Temporally controlled prostate tumorigenesis
###end title 37
###begin p 38
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Wang1">[20]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Ma1">[21]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Trotman1">[23]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Wang2">[25]</xref>
###xml 592 597 592 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 584 597 584 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 629 638 629 638 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7A</bold>
###xml 629 638 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g007"><bold>Figure 7A</bold></xref>
###xml 824 833 824 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7A</bold>
###xml 824 833 824 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g007"><bold>Figure 7A</bold></xref>
###xml 1063 1068 1063 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1055 1068 1055 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1096 1105 1096 1105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7B</bold>
###xml 1096 1105 1096 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g007"><bold>Figure 7B</bold></xref>
###xml 1151 1155 1151 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1274 1275 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1322 1323 1322 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1428 1433 1428 1433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1420 1433 1420 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1498 1499 1498 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1549 1550 1549 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1637 1638 1637 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1681 1682 1681 1682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1732 1741 1732 1741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7C</bold>
###xml 1732 1741 1732 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g007"><bold>Figure 7C</bold></xref>
###xml 1813 1818 1813 1818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1805 1818 1805 1818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1852 1853 1852 1853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1887 1888 1887 1888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1892 1893 1892 1893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1930 1939 1930 1939 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7C</bold>
###xml 1930 1939 1930 1939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g007"><bold>Figure 7C</bold></xref>
###xml 2022 2026 2022 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 425 430 <span type="species:ncbi:10090">mouse</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1434 1438 <span type="species:ncbi:10090">mice</span>
The advantage of the use of inducible CreERT/loxP technology in this report is that it allowed the monitoring of tumor development at specific time points after 4-OHT injection. To investigate the progression of Pten-deficient malignancies, prostate cancer progression was chosen as the initial model because a good understanding of the role of Pten in this disease has been gained from other prostate-specific Pten knockout mouse model studies [20], [21], [23], [25]. At 4 weeks, 6 weeks and 30 weeks after 4-OHT injection, we found gradually enlargement of the anterior prostate in R26-Ptenfx/fx mice compared to the controls (Figure 7A). Histologically, these prostate lesions were studied at the above time points (4, 6 and 30 weeks) and this revealed the prostate cancer progression through BPH/PIN to invasive cancer (Figure 7A). We then determined activation of AKT using antibody against phosphorylated AKT (p-AKT-Ser473) specifically. We found that AKT phosphorylation appeared in all prostate lesions along with hyperplasia and neoplasia in the R26-Ptenfx/fx mice, unlike the controls (Figure 7B). To identify the potential cell type of the Pten-deficient prostate cancer, we performed double immunofluorescent staining to verify the presence of cytokeratin 5 (CK5+)-expressing basal cells and cytokeratin 8 (CK8+)-expressing lumen epithelial cells from the normal, BPH, PIN and prostate cancer samples in the R26-Ptenfx/fx mice compared with the controls. Flattened and discontinuous CK5+-expressing cells were observed underneath the CK8+-expressing lumen epithelium in the control prostate, whereas stratification of the CK8+ lumen epithelium together with flatten CK5+ basal cells were noticed in the BPH/PIN lesions (Figure 7C). As the disease progressed to invasive prostate cancer in the R26-Ptenfx/fx males, focal expansion of the CK5+ cells and coexpression of the CK5+/CK8+ cells were significantly increased (Figure 7C). However, the significance of the increased CK5/CK8 double positive cells in the Pten-deficient prostate cancer remains unclear.
###end p 38
###begin title 39
###xml 42 47 42 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 34 47 34 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
Prostate tumor progression of the R26-Ptenfx/fx prostate.
###end title 39
###begin p 40
###xml 147 152 147 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 139 152 139 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 515 520 515 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 507 520 507 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 767 772 767 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 759 772 759 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
(A) Gross view (upper panels) and H&E staining (lower panels) of the anterior prostate of control (at 27 weeks 4OHT post-treatment) and of R26-Ptenfx/fx mice (at 4 weeks, 6 weeks and 30 weeks after 4OHT post-treatment); B, bladder; SV, seminal vesicle; AP (encircled in upper panels), anterior prostate; Arrows indicate the invasive border of the prostate epithelium and stroma. (B) IHC of p-AKT (Ser473) reveal the strong membranous localization of p-AKT in the BPH, PIN and prostate cancer samples of the R26-Ptenfx/fx mice compared to the normal epithelium of the control mice. (C) IF with antibodies against CK5 (green) and CK8 (red) reveal stratification and expansion of the basal and lumen epithelium in the BPH, PIN and prostate cancer samples of the R26-Ptenfx/fx mice compared to the normal epithelium of the control mice. Arrows indicate the focal CK5/CK8 (K5/K8) double-positive cells.
###end p 40
###begin title 41
The PI3K inhibitor, LY294002, suppresses prostate hyperplasia
###end title 41
###begin p 42
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 294 299 294 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 286 299 286 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 406 411 406 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 402 411 402 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 449 454 449 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 441 454 441 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 468 477 468 477 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8A</bold>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g008"><bold>Figure 8A</bold></xref>
###xml 634 639 634 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 626 639 626 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 679 688 679 688 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8B</bold>
###xml 679 688 679 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g008"><bold>Figure 8B</bold></xref>
###xml 896 901 896 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 888 901 888 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1009 1014 1009 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1001 1014 1001 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1055 1064 1055 1064 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8B</bold>
###xml 1055 1064 1055 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001237-g008"><bold>Figure 8B</bold></xref>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
We next evaluated the effect of the potential cancer targeting agent LY294002, which is a potent inhibitor of PI3K-AKT signaling pathway in Pten-deficient prostate tumor progression. After LY294002 treatment for 4 weeks, we found that the apparent increased anterior prostate weight in R26-Ptenfx/fx mice (n = 4) was significantly suppressed (p = 0.007) in comparison to the controls (LY294002-treated Ptenfx/fx mice, n = 3; vehicle-treated R26-Ptenfx/fx mice, n = 3; Figure 8A). Histological H&E staining revealed that the increased cellularity and nuclear atypia of the anterior prostate were diminished in LY294002 treated R26-Ptenfx/fx mice compared with the untreated mice (Figure 8B). We next examined whether LY294002 treatment blocked the PI3K-AKT signaling pathway. Using IHC, we found that only focal epithelial lesions showed pAKT(Ser473)-positive staining in LY294002 treated R26-Ptenfx/fx prostates, suggesting that LY294002 treatment strongly suppresses AKT phosphorylation at Ser473 in R26-Ptenfx/fx mice compared to the untreated animals (Figure 8B). Therefore, our results demonstrated that inhibition of the PI3K-AKT pathway was sufficient to suppress Pten-deficient prostate hyperplasia.
###end p 42
###begin title 43
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Suppressive effect of LY294002 on the Pten-deficient prostate enlargement.
###end title 43
###begin p 44
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 289 294 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 285 294 285 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 311 316 311 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 303 316 303 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 588 593 588 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 580 593 580 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
(A) The bar graph represented the relative weight (mean) of the anterior prostate lobe (AP weight in mg/body weight in g) of each group (n> = 3). The p value was calculated by Student's t-test. Error bars represent the standard derivation. (B) Dissected anterior prostates of control (Ptenfx/fx) and of R26-Ptenfx/fx mice in the absence or presence of LY294002 for 4 weeks; these are shown as a gross view (upper panels) and with H&E staining (middle panels). IHC of p-AKT(Ser473) is shown in the lower panels. Arrow indicates the focal positive for p-AKT in the LY294002-treated R26-Ptenfx/fx prostate.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 615 619 615 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 607 619 607 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 631 636 631 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 623 636 623 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1049 1053 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Sakai1">[30]</xref>
###xml 1123 1127 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Cairns1">[31]</xref>
###xml 1158 1162 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Risinger1">[32]</xref>
###xml 1183 1187 1183 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 1441 1445 1441 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Marsh1">[33]</xref>
###xml 1546 1550 1546 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Marsh1">[33]</xref>
###xml 1552 1556 1552 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Sansal1">[34]</xref>
###xml 1558 1562 1558 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Eng1">[35]</xref>
###xml 1599 1604 1599 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1591 1604 1591 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 1688 1692 1688 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 1682 1687 <span type="species:ncbi:9606">human</span>
In this study, we demonstrated that the tumor spectrum, tumor incidence and tumor latency during temporally controlled Pten loss in the mouse. This is the first in vivo analysis of Pten-deficient tumorigenesis in the systemic organs of the adult mouse. It is likely that lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the Pten gene is excised by 4OHT-induced Cre/loxP recombination in the mouse's adult tissues. Although we have observed that Cre-mediated Pten excision did slightly vary among the systemic organs of R26-Ptenfx/+ or R26-Ptenfx/fx mice, the variation seemed to show no correlation with the occurrence of Pten-deficient malignancies. Neoplastic cells may initiate from a single cell or a small number of cells because they are highly susceptible to tumorigenesis after PTEN loss and therefore slight variations in the Cre-mediated Pten excision will not affect the presence of such foci. Clinical studies have shown that somatic alterations of PTEN are found in proximately 5% of lymphomas[30], 29% of prostate cancer [31] and 34% of endometrial cancer [32]. Moreover, germline PTEN mutation shows strong linkage to Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS). These are inherited tumor predisposition syndromes in which hamartomas may develop in the central nervous system, gastrointestinal tract, skin, breast and thyroid [33]. Affected individuals of CD families also have a higher risk of malignancy in corresponding tissues [33], [34], [35]. Thus, our findings for the R26-Ptenfx/fx tumor malignancies resemble to some degree of the tumor spectrum observed in human PTEN genetic studies.
###end p 46
###begin p 47
###xml 63 68 63 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 55 68 55 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
Interestingly, the tumor latency and tumor spectrum of R26-Ptenfx/fx mice exhibit gender-bias. Pten-deficient females are predisposed to lymphoma with an early onset of about 7 weeks, which may preclude the formation of other malignancies; the result of this may be the overall gender differences in the tumor spectrum. Particularly, intestinal cancer was not observed in Pten-deficient females, which may partly be due to the longer period time required to develop intestinal cancer, namely 25 weeks to 35 weeks post 4OHT treatment in mutant male mice.
###end p 47
###begin p 48
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 103 107 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 95 107 95 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 318 322 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 310 322 310 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 380 387 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>+/&#8722;</sup></italic>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Stambolic2">[9]</xref>
###xml 625 628 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 668 672 668 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 660 672 660 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 873 877 873 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 893 896 893 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-DiCristofano1">[8]</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Suzuki1">[11]</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Podsypanina1">[12]</xref>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Freeman2">[36]</xref>
###xml 983 987 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Freeman2">[36]</xref>
###xml 1197 1201 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1454 1458 1454 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1629 1633 1629 1633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1693 1698 1693 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 1685 1698 1685 1698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 388 393 <span type="species:ncbi:10090">mouse</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 746 751 <span type="species:ncbi:10090">mouse</span>
###xml 857 862 <span type="species:ncbi:10090">mouse</span>
###xml 1057 1062 <span type="species:ncbi:10090">mouse</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
###xml 1396 1401 <span type="species:ncbi:10090">mouse</span>
###xml 1443 1447 <span type="species:ncbi:10090">mice</span>
###xml 1699 1703 <span type="species:ncbi:10090">mice</span>
Furthermore, we observed that only four mice heterozygous for the Pten floxed allele, among 21 R26-Ptenfx/+ mice analyzed, developed a variety of malignancies (up to 60 weeks).The incidence (19.0%, 4 of 21), latency (42 to 58 weeks) and spectrum (lung, breast and liver cancers) of the malignant tumors in our R26-Ptenfx/+ mice is quite different from that of a previous reported Pten+/- mouse model [9]. This report described approximately 18% lymphomas, 22% uterine cancer and 49% breast cancer occurring at ages ranging from 26 to 65 weeks. This discrepancy may be explained by the focal or mosaic excised activity of Cre/loxP-mediated recombination in the R26-Ptenfx/+ mice. In addition, it is possible that the genetic background of the two mouse models or some other undefined mechanism may affect the tumor latency and spectrum between the different mouse models of Pten heterozygosity [8], [11], [12], [36]. In a previous study, Freeman et al. reported that tumorigenesis in Pten heterozygotes was strongly affected by the genetic background of the mouse [36]. Mutant mice with a 129;C57BL6 background tend to have a higher incidence of lymphoid and endometrial malignancies. In contrast, Pten heterozygotes with a 129;BALB/c background develop prostate cancer more frequently. These findings are significant because they suggest that there are different modifier(s) present in different mouse strains that affect tumorigenesis in the mice after Pten loss. However, it remains unclear currently whether such background differences or putative modifier(s) are able to efficiently contribute to tumorigenesis in bi-allelic Pten loss. This might be further examined by generating R26-Ptenfx/fx mice with different genetic backgrounds or different mutant strains in the future.
###end p 48
###begin p 49
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 879 883 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Hu1">[37]</xref>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Bondar1">[38]</xref>
###xml 908 913 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1024 1028 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Shukla1">[39]</xref>
###xml 1093 1097 1093 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1486 1490 1486 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1510 1513 1510 1513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1506 1513 1506 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>+/&#8722;</sup></italic>
###xml 1519 1523 1519 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Yilmaz1">[24]</xref>
###xml 1525 1529 1525 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Kwon1">[40]</xref>
###xml 1531 1535 1531 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Milam1">[41]</xref>
###xml 1611 1615 1611 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1707 1711 1707 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 869 878 <span type="species:ncbi:10090">nude mice</span>
###xml 991 996 <span type="species:ncbi:9606">human</span>
###xml 1301 1306 <span type="species:ncbi:10090">mouse</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
Although the multiple tumors that occurred simultaneously in the Pten-deficient mice may have complicated the monitoring of tumor formation compared to other mouse models that have used Pten ablation in a tissue-specific manner, our study is able to provide knowledge that will help an understanding of Pten tumor suppressor functional requirements in multiple tissue lineages and cells. In addition, the latency of the different Pten-deficient cancers provides a valuable time frame for a more detailed dissection in the future of the downstream effectors of Pten loss using pharmacological or genetic approaches. In this study, we tested the pharmacological inhibition of the Pten downstream signaling cascade using the PI3K inhibitor, LY294002, which has been demonstrated to suppress tumor outgrowth in xenografted ovarian tumors and pancreatic cancer cells in the nude mice [37], [38]. Recently, Shukla et al showed that LY294002 treatment suppresses the invasive properties of several human prostate cancer cell lines [39]. In our study, we found that prostate hyperplasia after induced Pten loss at an adult stage is suppressed by LY294002. To our knowledge, this is the first evidence to show tumor inhibitory activity of LY294002 in spontaneous tumor formation using a genetically engineered mouse model. Moreover, recent reports have shown that mTOR inhibition effectively suppresses neuronal hypertrophy, endometrial hyperplasia and leukemia initiation after tissue-specific Pten loss or in the Pten+/- mice [24], [40], [41]. Likewise, mTOR inhibition could also be tested in our temporal controlled Pten-deficient tumor model and this will allow the dissection of mTOR pathway requirements when Pten is lost in systemic organs.
###end p 49
###begin p 50
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 388 393 388 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 373 393 373 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26CreER<sup>T</sup>; Pten<sup>fx/fx</sup></italic>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
In summary, we utilized an inducible Cre/loxP system to ablate Pten in a temporal-specific manner in the adult mouse. Through the monitoring of tumor spectrum, tumor latency and tumor incidence in the Pten-deficient mice, our findings provide an entry point for an understanding the role of Pten in tumorigenesis across different tissues. Furthermore, these 4OHT-inducible R26CreERT; Ptenfx/fx mice will be a useful mouse model that can be used to identify and study potential therapeutic approaches that will prevent Pten-deficient malignancies.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 52
###begin p 53
###xml 4 9 4 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 9 13 9 13 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Lesche1">[28]</xref>
###xml 15 19 15 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Groszer1">[29]</xref>
###xml 21 47 21 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26 Cre reporter (R26R)</italic>
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Mao1">[42]</xref>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26</italic>
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CreER<sup>T</sup></italic>
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Badea1">[27]</xref>
###xml 161 179 161 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER/+;R26R/+</italic>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 306 311 306 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 289 311 289 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>/+;Pten<sup>fx/fx</sup></italic>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 346 350 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 329 350 329 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>/+;Pten<sup>fx/+</sup></italic>
###xml 358 363 358 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 354 363 354 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 444 449 444 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 440 449 440 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 454 464 454 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup></italic>
###xml 510 511 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 518 522 518 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 501 522 501 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-CreER<sup>T</sup>/+;Pten<sup>fx/+</sup></italic>
###xml 531 536 531 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 527 536 527 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>fx/fx</sup></italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
Ptenfx/fx[28], [29], ROSA26 Cre reporter (R26R)[42] and R26-CreERT[27] mice were obtained from the Jackson Laboratory (Jackson Laboratory, Bar Harbor, ME, USA). R26-CreER/+;R26R/+ bigenic mice were generated in order to examine the effect of inducible Cre activity in the systemic organs. R26-CreERT/+;Ptenfx/fx and the control (R26-CreERT/+;Ptenfx/+ or Ptenfx/fx) mice were generated in a mixed background (BALB/c;129;C57BL/6) by crossing Ptenfx/fx and R26-CreERT mice; this was followed by crossing R26-CreERT/+;Ptenfx/+ and Ptenfx/fx mice. Up to five mice were housed in microisolator cages and provided with autoclaved food and water in a specific pathogen free colony. The experimental procedures using animals were in accordance with the guidelines of Institutional Animal Care and Use Committee. PCR genotyping was performed according to the standard protocols.
###end p 53
###begin title 54
Pharmacologically administration
###end title 54
###begin p 55
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
4-hydroxytamoxifen (4-OHT; Sigma-Aldrich, St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) at a concentration of 10 mg/ml. 4-OHT solution was emulsified in sunflower seed oil (Sigma-Aldrich) by vortexing, which was followed by mixing on a rotator for 4approximately6 hours. The mice at the age of 6 weeks were injected intraperitoneally with a dose of 4-OHT (4approximately5g per gram body weight) every other day three times. Similarly, LY294002 (Calbiochem, La Jolla, CA, USA) was prepared using the same procedure as 4-OHT. For the LY294002 administration, mice were injected intraperitoneally with LY294002 (4approximately5g per gram body weight) one week after the 4OHT treatment.
###end p 55
###begin title 56
Whole mount X-gal staining
###end title 56
###begin p 57
###xml 260 261 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The systemic organs including brain, lung, liver, spleen, pancreas, lung, kidney, stomach, intestine and reproductive system were dissected. Organs were fixed transiently with 10% neutral-buffered formalin for 30 minutes and rinsed with rinse buffer (2 mM MgCl2, 0.1% sodium deoxycholate, 0.2% NP-40, 1x PBS, pH7.3) for 30 minutes. Organs were incubated with X-gal staining solution (5 mM potassium hexacyanoferrate, 5 mM potassium hexacynoferrate trihydrate, 1 mg/ml X-gal in rinse buffer) for 1 hour at 37degreesC or room temperature with gentle agitation until the appearance of blue coloration and then organs in X-gal staining solution were transferred to 4degreesC refrigerator overnight. Finally, stained organs were post-fixed with neutral-buffered formalin overnight and stored in 70% ethanol at 4degreesC or photography examined by stereomicroscopy (MZ6, Leica, Germany).
###end p 57
###begin title 58
Analyses of tumor-free survival and tumor malignancy
###end title 58
###begin p 59
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Chen2">[43]</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001237-Chen3">[44]</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
The tumor-free survival rate was analyzed using the Kalpan-Meier method by the SPSS program (SPSS, Inc., Chicago, IL, USA). Detail analysis of tumor formation has been described previously [43], [44]. Briefly, mice were inspected for illness or tumor formation twice every week. Normal tissues or tumor samples were isolated and fixed in 10% neutral-buffered formalin at 4degreesC overnight. Subsequently, the samples were embedded in paraffin and further processed for histopathological studies as described below. Lung, kidney, liver and enlarged lymph nodes were also isolated to histologically to be examined for metastasis. If tumors were not identified by gross examination, then a necropsy was performed. Diagnosis of tumor malignancy was carried out in consultation with pathologists. In general, tissue sections stained by hematoxylin and eosin (H&E; see below) were examined by light microscopy (BX51, Olympus, Japan). Tumor malignancy was characterized by invasive behavior or metastasis. Expansive tumor lesions, but with a relatively normal cytological appearance and not showing an invasive behavior, were considered as benign or pre-cancerous.
###end p 59
###begin title 60
Hematoxylin and eosin (H&E) staining
###end title 60
###begin p 61
###xml 203 204 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Tissue sections on slides were deparaffinized and rehydrated and this was followed by staining with Harris Hematoxylin (DakoCytomation, Denmark) for 3approximately5 minutes. Sections were washed with ddH2O and then transferred to Tris-HCl (pH 8.0) for 5 minutes. Subsequently, the sections were stained with Eosin Y (Shandon, Tokyo, Japan) for 30 seconds, dehydrated and then mounted.
###end p 61
###begin title 62
Immunohistochemical (IHC) and immunofluorescence studies (IF)
###end title 62
###begin p 63
###xml 290 296 <span type="species:ncbi:9913">Bovine</span>
###xml 817 822 <span type="species:ncbi:10090">mouse</span>
###xml 823 829 <span type="species:ncbi:9986">rabbit</span>
###xml 1496 1499 <span type="species:ncbi:10116">rat</span>
###xml 1563 1569 <span type="species:ncbi:9986">rabbit</span>
Tissue sections were deparaffinized, rehydrated and placed in boiling antigen retrieval buffer (DakoCytomation). Endogenous peroxidase activity was quenched by 3% hydrogen peroxide for 5 minutes and this was followed by incubation with blocking reagent (1% Cold Water Fish Skin Gelatin, 5% Bovine Serum Albumin in 1x Phosphate Buffered Saline) for 1 hour at room temperature. For IHC, the tissues sections were subsequently incubated with primary antibodies against CD3 (ready to use; Abcam Ltd, Cambridge, UK), B220 (1:50 dilution; Southern Biotech, Birmingham, AL, USA;), E-cadherin (1:50 dilution; DakoCytomation) and p-AKT(Ser473) (1:100 dilution; Cell Signaling Technology, Beverly, MA, USA) for 1 hour at room temperature The tissue sections was then incubated with biotinylated-linked secondary antibody (anti-mouse/rabbit; DakoCytomation) for 30 minutes and Streptavidin-HRP (DakoCytomation) was added to amplify the signals. Staining was performed using a NovaRed substrate kit (Vector Laboratories, Burlingame, CA). The slides were counterstained for a short time with Hematoxylin, which was followed by dehydration and then mounting. For IF, tissues sections were incubated with primary antibodies against PTEN (1:12500 dilution; Cascade BioScience, Winchester, MA), cytokeratin 5 (CK5, 1:400 dilution; Abcam) and/or cytokeratin 8 (CK8 or TROMA-1, 1:400, Developmental Study Hybridoma Bank, University of Iowa, Iowa City, IA, USA). Secondary antibodies (AlexaFluor 568 conjugated anti-rat IgG against antibody to CK8 and AlexaFluor 488 conjugated anti-rabbit IgG against antibody to CK5; Molecular Probes, Invitrogen) were next incubated on the slides for 1 hour and this was followed by DAPI staining for 2 minutes. A tyramide signaling amplification (TSA) system (kit#22 with HRP-streptavidin and AlexaFluor 488, Invitrogen) was used to enhance the PTEN signal. Finally, the slides were further incubated with DAPI for 2 minutes and mounted in fluorescent mounting medium (DakoCytomation).
###end p 63
###begin title 64
Flow cytometry analysis
###end title 64
###begin p 65
The control or enlarged lymphoid organs (thymus and lymph nodes) were dissected and collected in DMEM medium. These lymphoid tissues were grounded and filtrated through cell strainers. The cells present were counted and then centrifuged for 5 minutes at 4degreesC. Then, the cell suspensions were incubated with 2.4G2 monoclonal antibody (a gift from Dr Jeffery J.Y. Yen) for 30 minutes on ice followed by labeling with FITC-conjugated antibodies against CD4 (eBioscience, San Diego, CA, USA) and PE-conjugated antibody against CD8 (eBioscience) for 15 minutes. After washing the cell pellets twice with 1xPBS, the cells were resuspended in 1xPBS containing Propidium Iodine (1g/ml, eBioscience). The percentage of live cells (PI exclusive) expressing the CD4/CD8 surface markers were analyzed by flow cytometry (FACScalibur, Becton Dickinson, USA) using Cell Quest software.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
###xml 227 231 227 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 219 231 219 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 244 249 244 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/fx</sup>
###xml 236 249 236 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/fx</sup></italic>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
Immunofluorescence analysis of PTEN expression. After one week of 4OHT injection, PTEN expression was determined using antibody against PTEN (green) and counterstained with DAPI (blue) in the lung and the kidney of the R26-Ptenfx/+ and R26-Ptenfx/fx mice.
###end p 67
###begin p 68
(1.01 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 125 129 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 117 129 117 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 401 405 401 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 393 405 393 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 591 595 591 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fx/+</sup>
###xml 583 595 583 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26-Pten<sup>fx/+</sup></italic>
###xml 642 643 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 727 742 727 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8764;D</italic>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
R26-Ptenfx/+ malignancies. (A) H&E-stained section of a lung cancer shows the bronchioloalveolar features found in a R26-Ptenfx/+ male at 42 weeks post 4OHT treatment. (B) H&E-stained section showing lung cancer metastasis in the liver of the same mouse described in A. (C) H&E-stained section of a mammary gland tumor showing lobular intraductal proliferation and microinvasion patterns in a R26-Ptenfx/+ female at 52 weeks. (D) H&E-stained section of a liver cancer showing disarrangement of the sinusoids, trabecular or pseudoglandular features with scattered hyaline bodies in a R26-Ptenfx/+ male at 58 weeks. High magnification views in C and D showing mitotic figures (arrowheads) have been inserted (Bar, 100m). Bars in AapproximatelyD, 200m. T, tumor lesion.
###end p 70
###begin p 71
(1.91 MB TIF)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
We thank Drs. Ming-Ji Fann and Yu-Ting Yan for helpful comments, Drs Ting-Fen Tsai and Ching-Wei Luo for sharing of reagents and equipments and Dr Ralph Kirby for proofreading of this manuscript.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
###end article-title 75
###begin article-title 76
The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
###end article-title 76
###begin article-title 77
PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
###end article-title 77
###begin article-title 78
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
###end article-title 78
###begin article-title 79
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
###end article-title 79
###begin article-title 80
###xml 62 67 <span type="species:ncbi:9606">human</span>
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
###end article-title 80
###begin article-title 81
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
###end article-title 81
###begin article-title 82
Pten is essential for embryonic development and tumour suppression.
###end article-title 82
###begin article-title 83
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
###end article-title 83
###begin article-title 84
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.
###end article-title 84
###begin article-title 85
###xml 113 117 <span type="species:ncbi:10090">mice</span>
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
###end article-title 85
###begin article-title 86
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.
###end article-title 86
###begin article-title 87
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.
###end article-title 87
###begin article-title 88
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
###end article-title 88
###begin article-title 89
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
###end article-title 89
###begin article-title 90
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.
###end article-title 90
###begin article-title 91
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
###end article-title 91
###begin article-title 92
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Conditional alleles in mice: practical considerations for tissue-specific knockouts.
###end article-title 92
###begin article-title 93
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Site- and time-specific gene targeting in the mouse.
###end article-title 93
###begin article-title 94
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.
###end article-title 94
###begin article-title 95
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
###end article-title 95
###begin article-title 96
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten.
###end article-title 96
###begin article-title 97
Pten dose dictates cancer progression in the prostate.
###end article-title 97
###begin article-title 98
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.
###end article-title 98
###begin article-title 99
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
###end article-title 99
###begin article-title 100
PTEN-deficient intestinal stem cells initiate intestinal polyposis.
###end article-title 100
###begin article-title 101
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.
###end article-title 101
###begin article-title 102
###xml 38 44 <span type="species:ncbi:10090">murine</span>
Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.
###end article-title 102
###begin article-title 103
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.
###end article-title 103
###begin article-title 104
PTEN gene alterations in lymphoid neoplasms.
###end article-title 104
###begin article-title 105
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
###end article-title 105
###begin article-title 106
PTEN/MMAC1 mutations in endometrial cancers.
###end article-title 106
###begin article-title 107
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
###end article-title 107
###begin article-title 108
The biology and clinical relevance of the PTEN tumor suppressor pathway.
###end article-title 108
###begin article-title 109
Will the real Cowden syndrome please stand up: revised diagnostic criteria.
###end article-title 109
###begin article-title 110
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Genetic background controls tumor development in PTEN-deficient mice.
###end article-title 110
###begin article-title 111
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).
###end article-title 111
###begin article-title 112
Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo.
###end article-title 112
###begin article-title 113
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
###end article-title 113
###begin article-title 114
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.
###end article-title 114
###begin article-title 115
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.
###end article-title 115
###begin article-title 116
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice.
###end article-title 116
###begin article-title 117
Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.
###end article-title 117
###begin article-title 118
Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts.
###end article-title 118
###begin p 119
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 119
###begin p 120
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Supported by the Ministry of Education, Aim for the Top University Plan and the National Science Council, Taiwan, (NSC 95-2320-B-010-004, NSC 95-2320-B-010-014 and NSC 96-3112-B-010-016) to C-MC. Supported by the Research Foundation of Taoyuan Armed Forces General Hospital (9519 and 9612) to J-LC.
###end p 120

